Atlas Trials

Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab

Clinical trial NCT04779151 · TERMINATED

Trial details

NCT number
NCT04779151
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Urothelial Bladder CancerGastric AdenocarcinomaGastro-oesophageal AdenocarcinomaHead and Neck CancerBiliary Tract CancerPlatinum-sensitive Urothelial Bladder CancerClear Cell Renal Cell CarcinomaPancreatic Ductal Adenocarcinoma
Start date
2021-04-07
Primary completion
2025-02-25
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.